Literature DB >> 21036725

Soluble MICB serum levels correlate with disease stage and survival rate in patients with oral squamous cell carcinoma.

Shigehiro Tamaki1, Masayoshi Kawakami, Akiko Ishitani, Wataru Kawashima, Shogo Kasuda, Yasutsugu Yamanaka, Hiroyuki Shimomura, Yuichiro Imai, Yousuke Nakagawa, Katsuhiko Hatake, Tadaaki Kirita.   

Abstract

BACKGROUND: Expression of ligands of natural killer group 2D (NKG2D) immunoreceptors, such as major histocompatibility complex class I-related chain A/B (MICA/B), has been proposed to play an important role in tumour immunosurveillance. Soluble forms of MICA/B are increased in sera of cancer patients and are postulated to impair antitumour immune response by downregulating expression of NKG2D immunoreceptors. Serum levels of soluble MICA have been shown to be of diagnostic significance in malignant diseases. AIMS: The potential of soluble MICB (sMICB) as a marker for oral squamous cell carcinoma (OSCC) was investigated.
RESULTS: sMICB levels did not differ significantly from those in normal control individuals. However, the findings indicate that sMICB levels are significantly increased in stage IV OSCC and high sMICB levels are significantly associated with decreased survival rates in patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036725

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  15 in total

1.  Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis.

Authors:  Gang Liu; Shengjun Lu; Xuanjun Wang; Stephanie T Page; Celestia S Higano; Stephen R Plymate; Norman M Greenberg; Shaoli Sun; Zihai Li; Jennifer D Wu
Journal:  J Clin Invest       Date:  2013-09-09       Impact factor: 14.808

Review 2.  NKG2D and its ligands in cancer.

Authors:  Payal Dhar; Jennifer D Wu
Journal:  Curr Opin Immunol       Date:  2018-03-09       Impact factor: 7.486

3.  Soluble MICA is elevated in pancreatic cancer: Results from a population based case-control study.

Authors:  Guillaume Onyeaghala; Heather H Nelson; Bharat Thyagarajan; Amy M Linabery; Angela Panoskaltsis-Mortari; Myron Gross; Kristin E Anderson; Anna E Prizment
Journal:  Mol Carcinog       Date:  2017-05-24       Impact factor: 4.784

4.  Increased sMICA and TGFβ1 levels in HNSCC patients impair NKG2D-dependent functionality of activated NK cells.

Authors:  Stephan Klöß; Nicole Chambron; Tanja Gardlowski; Lubomir Arseniev; Joachim Koch; Ruth Esser; Wolfgang Glienke; Oliver Seitz; Ulrike Köhl
Journal:  Oncoimmunology       Date:  2015-05-29       Impact factor: 8.110

Review 5.  Molecular Bases for the Regulation of NKG2D Ligands in Cancer.

Authors:  Leticia Huergo-Zapico; Andrea Acebes-Huerta; Alejandro López-Soto; Mónica Villa-Álvarez; Ana Pilar Gonzalez-Rodriguez; Segundo Gonzalez
Journal:  Front Immunol       Date:  2014-03-21       Impact factor: 7.561

6.  Circulating levels of soluble MICB in infants with symptomatic primary dengue virus infections.

Authors:  Daniel H Libraty; Lei Zhang; AnaMae Obcena; Job D Brion; Rosario Z Capeding
Journal:  PLoS One       Date:  2014-05-28       Impact factor: 3.240

7.  Soluble MICB protein levels and platelet counts during hepatitis B virus infection and response to hepatocellular carcinoma treatment.

Authors:  Hoang Van Tong; Le Huu Song; Nghiem Xuan Hoan; Bui Khac Cuong; Bui Tien Sy; Ho Anh Son; Do Quyet; Vu Quoc Binh; Peter G Kremsner; Claus Thomas Bock; Thirumalaisamy P Velavan; Nguyen Linh Toan
Journal:  BMC Infect Dis       Date:  2015-01-23       Impact factor: 3.090

8.  Elevation of soluble major histocompatibility complex class I related chain A protein in malignant and infectious diseases in Chinese patients.

Authors:  Xiaoxin Jiang; Ju-Fang Huang; Zhi Huo; Qiuqui Zhang; Yan Jiang; Xiaoping Wu; Yanwen Li; Guanmin Jiang; Leping Zeng; Xiao-Xin Yan; Ping Yu; Renxian Cao
Journal:  BMC Immunol       Date:  2012-11-26       Impact factor: 3.615

9.  Cetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids.

Authors:  Stephan Klöss; Nicole Chambron; Tanja Gardlowski; Sandra Weil; Joachim Koch; Ruth Esser; Elke Pogge von Strandmann; Michael A Morgan; Lubomir Arseniev; Oliver Seitz; Ulrike Köhl
Journal:  Front Immunol       Date:  2015-11-02       Impact factor: 7.561

Review 10.  Secretory pathways generating immunosuppressive NKG2D ligands: New targets for therapeutic intervention.

Authors:  Aroa Baragaño Raneros; Beatriz Suarez-Álvarez; Carlos López-Larrea
Journal:  Oncoimmunology       Date:  2014-04-25       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.